Lyell Immunopharma, Inc.
LYEL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001806952
In the last 90 days, Lyell Immunopharma, Inc. insiders filed 0 open-market purchases and 10 sales; 87 institutions reported holding it in 13F filings for Q2 2026, worth $178.0M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Lyell Immunopharma, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 120 | 2 | 117 | −1 |
| Shares | 133.6M | 13.6M | 128.4M | +8.48M (+7.1%) |
| Value | $194.2M | $19.8M | $176.6M | +$2.09M (+1.2%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Lyell Immunopharma, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 13,747,084 | $19.0M | 0.00% |
| HRT Financial LP | 569,016 | $785.0K | 0.00% |
| Squarepoint Ops LLC | 135,500 | $187.0K | 0.00% |
| Shell Asset Management Co | 127,985 | $177.0K | 0.01% |
| Susquehanna International Group, LLP | 119,312 | $164.7K | 0.00% |
| AQR Capital Management LLC | 117,125 | $161.6K | 0.00% |
| SEI Investments Co | 55,900 | $77.1K | 0.00% |
| Point72 Asia (Singapore) Pte. Ltd. | 37,704 | $52.0K | 0.01% |
| Intech Investment Management LLC | 37,495 | $51.7K | 0.00% |
| Public Employees Retirement Association of Colorado | 23,132 | $32.0K | 0.00% |
| Centiva Capital, LP | 22,160 | $30.6K | 0.00% |
| Paloma Partners Management Co | 16,841 | $23.2K | 0.00% |
| EP Wealth Advisors, LLC | 14,204 | $19.6K | 0.00% |
| Point72 (DIFC) Ltd | 3,550 | $4.90K | 0.00% |
| Global Retirement Partners, LLC | 3,096 | $4.27K | 0.00% |
| Sterling Capital Management LLC | 510 | $704 | 0.00% |
| True Wealth Design, LLC | 313 | $432 | 0.00% |
| Smartleaf Asset Management LLC | 267 | $403 | 0.00% |
| Capital Performance Advisors LLP | 171 | $236 | 0.00% |
Sold out (20)
Institutions that held Lyell Immunopharma, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Massachusetts Financial Services Co | 577,319 | $837.1K |
| Wellington Management Group LLP | 367,677 | $533.1K |
| American Century Companies Inc | 279,425 | $405.2K |
| Franklin Resources Inc | 98,652 | $143.0K |
| XTX Topco Ltd | 70,174 | $101.8K |
| Mercer Global Advisors Inc | 40,397 | $58.6K |
| Jacobs Levy Equity Management, Inc | 31,184 | $45.2K |
| Woodline Partners LP | 20,740 | $30.1K |
| JustInvest LLC | 18,682 | $27.1K |
| Simplicity Wealth,LLC | 18,412 | $26.7K |
| Bleakley Financial Group, LLC | 18,412 | $26.7K |
| Omers Administration Corp | 14,200 | $20.6K |
| Federated Hermes, Inc. | 11,688 | $16.9K |
| Russell Investments Group, Ltd. | 11,476 | $16.6K |
| Simplex Trading, LLC | 3,362 | $4.00K |
| Tyler-Stone Wealth Management | 850 | $1.23K |
| Macquarie Group Ltd | 505 | $732 |
| Riggs Asset Managment Co. Inc. | 150 | $218 |
| Rothschild Investment LLC | 50 | $73 |
| Capital Advisors, Ltd. LLC | 154 | $0 |
Not filed for Q3 2024 yet (2)
Institutions that held Lyell Immunopharma, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 13,495,132 | $19.6M |
| Susquehanna Fundamental Investments, LLC | 128,203 | $185.9K |